10-46010437-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001145263.2(NCOA4):c.1484C>T(p.Ser495Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00227 in 1,614,176 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0023 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 23 hom. )
Consequence
NCOA4
NM_001145263.2 missense
NM_001145263.2 missense
Scores
1
2
4
Clinical Significance
Conservation
PhyloP100: 5.32
Genes affected
NCOA4 (HGNC:7671): (nuclear receptor coactivator 4) This gene encodes an androgen receptor coactivator. The encoded protein interacts with the androgen receptor in a ligand-dependent manner to enhance its transcriptional activity. Chromosomal translocations between this gene and the ret tyrosine kinase gene, also located on chromosome 10, have been associated with papillary thyroid carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes are present on chromosomes 4, 5, 10, and 14. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014239132).
BP6
Variant 10-46010437-G-A is Benign according to our data. Variant chr10-46010437-G-A is described in ClinVar as [Benign]. Clinvar id is 715257.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00226 (344/152298) while in subpopulation EAS AF= 0.0189 (98/5184). AF 95% confidence interval is 0.0159. There are 3 homozygotes in gnomad4. There are 166 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCOA4 | NM_001145263.2 | c.1484C>T | p.Ser495Leu | missense_variant | 8/10 | ENST00000581486.6 | NP_001138735.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCOA4 | ENST00000581486.6 | c.1484C>T | p.Ser495Leu | missense_variant | 8/10 | 1 | NM_001145263.2 | ENSP00000462943.1 |
Frequencies
GnomAD3 genomes AF: 0.00227 AC: 345AN: 152182Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
345
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00451 AC: 1132AN: 251246Hom.: 8 AF XY: 0.00415 AC XY: 564AN XY: 135876
GnomAD3 exomes
AF:
AC:
1132
AN:
251246
Hom.:
AF XY:
AC XY:
564
AN XY:
135876
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00227 AC: 3319AN: 1461878Hom.: 23 Cov.: 32 AF XY: 0.00234 AC XY: 1705AN XY: 727236
GnomAD4 exome
AF:
AC:
3319
AN:
1461878
Hom.:
Cov.:
32
AF XY:
AC XY:
1705
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00226 AC: 344AN: 152298Hom.: 3 Cov.: 32 AF XY: 0.00223 AC XY: 166AN XY: 74470
GnomAD4 genome
AF:
AC:
344
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
166
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
73
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.;.;.
LIST_S2
Benign
.;T;T;.;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T
Sift4G
Uncertain
D;D;D;D;D;D;D
Vest4
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at